Announcements Trials
Browse Landscape

Phase

Phase 1 56Phase 2 53Phase 1/2 38Phase 3 4Phase 2/3 4Phase EARLY_PHASE1 2Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Leukemia, Myeloid, Acute 4Pathologic Processes 1Neoplasms 1Myelodysplastic Syndromes 1Hematologic Diseases 1Bone Marrow Diseases 1

Interventions

posaconazole 2fludarabine 2Cyclophosphamide 2Busulfan 2fludarabine phosphate 1eltrombopag 1Thiotepa 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Micafungin 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Decitabine 1Cytarabine 1Cholecalciferol 1Bone Marrow Transplantation 1Azacitidine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Myelodysplastic Syndromes × Azacitidine × Clear all
NCT01201811 2019-12-05

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Celgene

Phase 4 Completed
44 enrolled 26 charts
Myeloid

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Neoplasms, Pathologic Processes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡